Leonardo Jaimes, MD

All articles by Leonardo Jaimes, MD

• Ipsen launches new trial studying potential PBC treatment

  Ipsen is recruiting participants for a trial assessing the safety and efficacy of elafibranor in primary biliary cholangitis (PBC).

• New gene potentially linked to PBC in recent study

  A recent study showed the PTPN2 gene may be associated with increased risk for primary biliary cholangitis (PBC).

• Phase 3 trial shows elafibranor safe and effective in PBC

  The drug elafibranor appears to be effective and safe for the treatment of primary biliary cholangitis (PBC) in a phase 3 trial.